NASDAQ · NEO
NeoGenomics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for NEO has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $-0.01 | $0.00 | $-0.02 | 2 |
| Mar 2027 | $-0.01 | $-0.01 | $-0.02 | 2 |
| Jun 2027 | $0.03 | $0.04 | $0.01 | 2 |
| Sep 2027 | $0.02 | $0.04 | $0.00 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
MarketBeat · The Motley Fool · Fintel · Zacks- MarketBeat · Oct 29, 1:04 AM EDTWhat NeoGenomics (NEO) Said on Its Q3 Earnings CallIt's Not Too Late to Jump on These Under-the-Radar Momentum PlaysNeoGenomics (NASDAQ:NEO) reported third-quarter revenue growth of 11% year over year, led by continued expansion in next-generation sequencing, or NGS, testing, while raising its full-year revenue and adjusted EBITD
- The Motley Fool · Oct 29, 12:13 AM EDTNeoGenomics (NEO) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Fintel · Oct 28, 8:31 PM EDTNeoGenomics, Inc. Reports Third Quarter 2026 Total Revenue of $209 millionNeoGenomics, Inc. reported its financial results for the third quarter ended September 30, 2026, with total revenue increasing 11% year-over-year to $209 million. Clinical revenue grew 13% to $195 million, driven by NGS growth of 29%. The company's GAAP gross margin expanded by 3
- Zacks · Oct 28, 6:30 PM EDTNeoGenomics (NEO) Q3 Earnings and Revenues Beat EstimatesNeoGenomics (NEO) delivered earnings and revenue surprises of +16.67% and +0.66%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Fintel · Oct 6, 9:07 PM EDTBTIG Upgrades NeoGenomics to Buy from NeutralFintel reports that on October 6, 2026, BTIG upgraded their outlook for NeoGenomics (NASDAQCM:NEO) (DB:NG9) from Neutral to Buy. This rating action occurred alongside other analyst activities on the same day. On October 6, 2026, there were 3 total analyst actions recorded for the
- Zacks · Sep 24, 12:42 PM EDTWhy Women-Run Companies Deserve a Place in Your PortfolioBMY, HALO, TGT, NEO and ROST stocks show how women-led companies are redefining growth with discipline, agility and results.
- NASDAQ.com · Sep 23, 2:00 PM EDTAfter-Hours Earnings Report for September 23, 2026 : FUL, SFIX, NEOVThe following companies are expected to report earnings after hours on 09/23/2026. Visit our Earnings Calendar for a full list of expected earnings releases.H. B. Fuller Company (FUL)is reporting for the quarter ending August 31, 2026. The chemical company's consensus earnings p
- RTTNews · Sep 22, 9:53 AM EDTBiotech Stocks At 52-Week Highs – AMRX, BLSM, NEOG. NEO(RTTNews) – The following biotech stocks reached a 52-week high on September 22, 2026, driven by key catalysts such as positive quarterly reports or results from clinical trials.
- MarketBeat · Sep 20, 10:02 PM EDTNeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley ConferenceIt's Not Too Late to Jump on These Under-the-Radar Momentum PlaysNeoGenomics (NASDAQ:NEO) executives outlined the company’s strategy to expand its role in community-based precision oncology, emphasizing growth in next-generation sequencing, minimal residual disease testing and wo
- RTTNews · Sep 18, 4:36 AM EDTBiotech Stocks At 52-Week Highs – MNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO(RTTNews) – The following biotech stocks reached a 52-week high on September 17, 2026, driven by the gain on certain clinical or financial results.
- Zacks · Sep 18, 3:45 AM EDTNovavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Zacks · Sep 8, 12:46 PM EDT3 Promising Genomics Stocks in the Spotlight in 2026Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicine.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for NeoGenomics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.